ABT-737 Induces Apoptosis in Mantle Cell Lymphoma Cells With a BCL-2high/McL-1low Profile and Synergizes With Other Antineoplastic Agents

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-0955
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Glycolysis Inhibition Targets McL-1 to Restore Sensitivity of Lymphoma Cells to ABT-737-induced Apoptosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

ABT-737, a Small Molecule BCL-2/BCL-xL Antagonist, Increases Antimitotic-Mediated Apoptosis in Human Prostate Cancer Cells

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2013English

The BH3 Mimetic Drug ABT-737 Induces Apoptosis and Acts Synergistically With Chemotherapeutic Drugs in Thyroid Carcinoma Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2016English

Synergistic BCL-2 Inhibition by ABT-737 and Cyclosporine A

Apoptosis : an international journal on programmed cell death
Cell BiologyPharmacologyBiochemistryClinical BiochemistryCancer ResearchPharmaceutical Science
2012English

Combined Administration of Rituximab and ON 013105 Induces Apoptosis in Mantle Cell Lymphoma Cells and Reduces Tumor Burden in a Mouse Model of Mantle Cell Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2012English

Loss in McL-1 Function Sensitizes Non-Hodgkin’s Lymphoma Cell Lines to the BCL-2-selective Inhibitor Venetoclax (ABT-199)

Blood Cancer Journal
OncologyHematology
2015English

Interleukin-21 Effectively Induces Apoptosis in Mantle Cell Lymphoma Through a STAT1-dependent Mechanism

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Crystal Structure of ABT-737 Complexed With BCL-xL: Implications for Selectivity of Antagonists of the BCL-2 Family

Cell Death and Differentiation
Cell BiologyMolecular Biology
2007English

Long-Term Outcomes and Mutation Profiling of Patients With Mantle Cell Lymphoma (MCL) Who Discontinued Ibrutinib

British Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy